You just read:

FDA Approves Lexicon Drug XERMELO™ (telotristat ethyl) 250 mg As First And Only Oral Treatment For Carcinoid Syndrome Diarrhea In Cancer Patients With Metastatic Neuroendocrine Tumors

News provided by

Lexicon Pharmaceuticals, Inc.

28 Feb, 2017, 15:56 ET